Literature DB >> 21566530

Early diagnosis of Horner syndrome using topical apraclonidine.

Johnathan Cooper-Knock1, Irene Pepper, Timothy Hodgson, Basil Sharrack.   

Abstract

The diagnosis of Horner syndrome (HS) using apraclonidine eye drops is an alternative to the use of topical cocaine drops. A number of reports have described the efficacy of apraclonidine testing, but there is some debate over its sensitivity in the acute setting. We describe a patient with HS secondary to carotid dissection who had a positive response to apraclonidine 3 hours after the onset of symptoms. The case is made for a larger study of apraclonidine use to determine its true sensitivity and specificity, identify confounding factors, and redefine the criteria for positive testing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566530     DOI: 10.1097/WNO.0b013e31821a91fe

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  4 in total

1.  Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.

Authors:  Amgad A Eldib; Preeti Patil; Ken K Nischal; Ellen R Mitchell; Jamila G Hiasat; Matthew S Pihlblad
Journal:  J AAPOS       Date:  2021-11-02       Impact factor: 1.220

2.  Horner's syndrome in patients admitted to the intensive care unit that have undergone central venous catheterization: a prospective study.

Authors:  Z Butty; J Gopwani; S Mehta; E Margolin
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

3.  Efficacy of digital pupillometry for diagnosis of Horner syndrome.

Authors:  Yung Ju Yoo; Hee Kyung Yang; Jeong-Min Hwang
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

Review 4.  Horner syndrome: clinical perspectives.

Authors:  Sivashakthi Kanagalingam; Neil R Miller
Journal:  Eye Brain       Date:  2015-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.